[go: up one dir, main page]

PT2076268E - Roscovitina para o tratamento de certas doenças císticas - Google Patents

Roscovitina para o tratamento de certas doenças císticas

Info

Publication number
PT2076268E
PT2076268E PT78528726T PT07852872T PT2076268E PT 2076268 E PT2076268 E PT 2076268E PT 78528726 T PT78528726 T PT 78528726T PT 07852872 T PT07852872 T PT 07852872T PT 2076268 E PT2076268 E PT 2076268E
Authority
PT
Portugal
Prior art keywords
roscovitine
treatment
cystic diseases
certain
certain cystic
Prior art date
Application number
PT78528726T
Other languages
English (en)
Inventor
Nikolay O Bukanov
Oxana Beskrovnaya
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38988354&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT2076268(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genzyme Corp filed Critical Genzyme Corp
Publication of PT2076268E publication Critical patent/PT2076268E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT78528726T 2006-10-19 2007-10-19 Roscovitina para o tratamento de certas doenças císticas PT2076268E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US85276006P 2006-10-19 2006-10-19

Publications (1)

Publication Number Publication Date
PT2076268E true PT2076268E (pt) 2013-03-07

Family

ID=38988354

Family Applications (1)

Application Number Title Priority Date Filing Date
PT78528726T PT2076268E (pt) 2006-10-19 2007-10-19 Roscovitina para o tratamento de certas doenças císticas

Country Status (11)

Country Link
US (2) US20110046164A1 (pt)
EP (2) EP2076268B1 (pt)
JP (2) JP5550906B2 (pt)
DK (1) DK2076268T3 (pt)
ES (1) ES2402907T3 (pt)
HR (1) HRP20130159T1 (pt)
PL (1) PL2076268T3 (pt)
PT (1) PT2076268E (pt)
RS (1) RS52737B (pt)
SI (1) SI2076268T1 (pt)
WO (1) WO2008051502A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA93548C2 (uk) 2006-05-05 2011-02-25 Айерем Елелсі Сполуки та композиції як модулятори хеджхогівського сигнального шляху
EP2076268B1 (en) * 2006-10-19 2013-01-23 Genzyme Corporation Roscovitine for the treatment of certain cystic diseases
PE20100362A1 (es) 2008-10-30 2010-05-27 Irm Llc Derivados de purina que expanden las celulas madre hematopoyeticas
WO2010103473A1 (en) 2009-03-10 2010-09-16 Chu De Brest Method of treatment of polycystic diseases and chronic lymphocytic leukemia
UA115388C2 (uk) 2013-11-21 2017-10-25 Пфайзер Інк. 2,6-заміщені пуринові похідні та їх застосування в лікуванні проліферативних захворювань
JP2020525446A (ja) * 2017-06-21 2020-08-27 ザ・ジョンズ・ホプキンス・ユニバーシティ 常染色体優性多発性嚢胞腎疾患を治療するための嚢胞性線維症膜貫通コンダクタンス制御因子の調節因子
CN112794853B (zh) * 2021-01-12 2021-11-30 江汉大学 一种有机硒化合物及其制备方法与应用
CN112794852B (zh) * 2021-01-12 2021-11-30 江汉大学 一种含硒有机化合物及其制备方法与应用
US12208084B1 (en) 2024-09-24 2025-01-28 Imam Mohammad Ibn Saud Islamic University Method of treating cancer in a subject

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3536809A (en) 1969-02-17 1970-10-27 Alza Corp Medication method
US3598123A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4008719A (en) 1976-02-02 1977-02-22 Alza Corporation Osmotic system having laminar arrangement for programming delivery of active agent
US4410545A (en) 1981-02-13 1983-10-18 Syntex (U.S.A.) Inc. Carbonate diester solutions of PGE-type compounds
US4328245A (en) 1981-02-13 1982-05-04 Syntex (U.S.A.) Inc. Carbonate diester solutions of PGE-type compounds
US4409239A (en) 1982-01-21 1983-10-11 Syntex (U.S.A.) Inc. Propylene glycol diester solutions of PGE-type compounds
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
IE58110B1 (en) 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
US5052558A (en) 1987-12-23 1991-10-01 Entravision, Inc. Packaged pharmaceutical product
US5073543A (en) 1988-07-21 1991-12-17 G. D. Searle & Co. Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
US5033352A (en) 1989-01-19 1991-07-23 Yamaha Corporation Electronic musical instrument with frequency modulation
IT1229203B (it) 1989-03-22 1991-07-25 Bioresearch Spa Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
US5120548A (en) 1989-11-07 1992-06-09 Merck & Co., Inc. Swelling modulated polymeric drug delivery device
US5733566A (en) 1990-05-15 1998-03-31 Alkermes Controlled Therapeutics Inc. Ii Controlled release of antiparasitic agents in animals
GB9126209D0 (en) 1991-12-10 1992-02-12 Orion Yhtymae Oy Drug formulations for parenteral use
US5580578A (en) 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5323907A (en) 1992-06-23 1994-06-28 Multi-Comp, Inc. Child resistant package assembly for dispensing pharmaceutical medications
US5591767A (en) 1993-01-25 1997-01-07 Pharmetrix Corporation Liquid reservoir transdermal patch for the administration of ketorolac
IT1270594B (it) 1994-07-07 1997-05-07 Recordati Chem Pharm Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
FR2741881B1 (fr) * 1995-12-01 1999-07-30 Centre Nat Rech Scient Nouveaux derives de purine possedant notamment des prorietes anti-proliferatives et leurs applications biologiques
US6350458B1 (en) 1998-02-10 2002-02-26 Generex Pharmaceuticals Incorporated Mixed micellar drug deliver system and method of preparation
CZ27399A3 (cs) * 1999-01-26 2000-08-16 Ústav Experimentální Botaniky Av Čr Substituované dusíkaté heterocyklické deriváty, způsob jejich přípravy, tyto deriváty pro použití jako léčiva, farmaceutická kompozice a kombinovaný farmaceutický přípravek tyto deriváty obsahující a použití těchto derivátů pro výrobu léčiv
GB0017084D0 (en) * 2000-07-13 2000-08-30 Univ Bristol Inhibition of the cystic fibrosis transmembrane conductance regulator chloride channel
US6667311B2 (en) * 2001-09-11 2003-12-23 Albany Molecular Research, Inc. Nitrogen substituted biaryl purine derivatives as potent antiproliferative agents
MXPA06012446A (es) * 2004-04-29 2007-01-17 Genzyme Corp Metodos y composiciones para el tratamiento de enfermedades poliquisticas.
WO2006012310A2 (en) * 2004-06-25 2006-02-02 Genzyme Corporation Carbazole derivatives for treating polycystic kidney disease
FR2876583B1 (fr) * 2004-10-15 2007-04-13 Centre Nat Rech Scient Cnrse Utilisation de derives de purines pour la fabrication de medicaments pour le traitement de la mucoviscidose et de maladies liees a un defaut d'adressage des proteines dans les cellules
EP2076268B1 (en) * 2006-10-19 2013-01-23 Genzyme Corporation Roscovitine for the treatment of certain cystic diseases

Also Published As

Publication number Publication date
JP5550906B2 (ja) 2014-07-16
PL2076268T3 (pl) 2013-06-28
RS52737B (en) 2013-08-30
SI2076268T1 (sl) 2013-04-30
JP2010506938A (ja) 2010-03-04
DK2076268T3 (da) 2013-04-22
HRP20130159T1 (hr) 2013-03-31
JP2014169321A (ja) 2014-09-18
WO2008051502A1 (en) 2008-05-02
US20140249165A1 (en) 2014-09-04
EP2076268B1 (en) 2013-01-23
ES2402907T3 (es) 2013-05-10
EP2617423A1 (en) 2013-07-24
US20110046164A1 (en) 2011-02-24
EP2076268A1 (en) 2009-07-08

Similar Documents

Publication Publication Date Title
IL186749A0 (en) Dihydrothienopyrimidines for the treatment of inflammatory diseases
GB0602178D0 (en) Therapeutic treatment
IL194076A0 (en) Imidazolothiazole compounds for the treatment of disease
SI2056842T1 (sl) Modificiran galaktosil-ceramid za zdravljenje kancerogenih obolenj
IL193747A0 (en) New therapeutic combinations for the treatment of depression
SI2044111T1 (sl) Ciljanje komplementa faktorja H za zdravljenje bolezni
HK1154382A1 (en) Triazole derivatives useful for the treatment of diseases
IL196202A0 (en) Indazole derivatives for the treatment of hsp90-induced diseases
GB0608655D0 (en) Therapeutic Treatment
PL2076268T3 (pl) Roskowityna do leczenia pewnych chorób torbielowatych
PT2056863T (pt) Tratamento de doenças oculares
HK1113319A1 (en) Use of docosahexaenoic triglycerides for the treatment of tumorous diseases
GB0610909D0 (en) Therapeutic treatment
IL192933A0 (en) Benzoisoindole derivatives for the treatment of pain
GB0523961D0 (en) The treatment of ophthalmic diseases
GB0623740D0 (en) Treatment of disease
GB0622136D0 (en) Treatment of gastrointestinal diseases
GB0523964D0 (en) The treatment of ophthalmic diseases
GB0602857D0 (en) The treatment of sialorrhoea
GB0610376D0 (en) Therapeutic treatment
GB0622137D0 (en) Treatment of gastrointestinal diseases
AU2006902723A0 (en) Therapeutic treatment
ZA200806180B (en) Benzoisoindole derivatives for the treatment of pain
GB0602855D0 (en) The Treatment Of Sialorrhoea
GB0602858D0 (en) The treatment of sialorrhoea